Abstract: The sensitivity of diagnostic criteria for BD in patients from the United States (US) is unknown. We compared the sensitivity of the 6 major diagnostic criteria in 164 consecutive US Behcet patients diagnosed clinically over a 12 year period. Patients were not prospectively evaluated and pathergy testing was carried out in only 27 of these patients. The sensitivity of these criteria was evaluated in the entire group, in the 27 ...
Treatment of Ocular Manifestations of Behcet's Disease.
Abstract: Purpose: Ocular lesions are the major cause of morbidity in Behcet's Disease. Cytotoxic drugs are the main therapeutic agents. We present here a comparative study of 8 methods in 1056 treated cases. Materials & Methods: In an open, nonrandomized control study, Pulse Cyclophosphamide (PCP), low dose PCP (LDP), oral Cyclophosphamide (OCP), weakly methotrexate (MTX), chlorambucil (CHL), cyclosporine A (CYA), azathioprine (AZA), and combination therapy with LDP and MTX (COM) were used ...